The potential anti-tumor effect of anesthetics on cancer by regulating autophagy

Tiantian Wang1,2,3, Zhixia Zhou2, Kai Jiang3

  • 1School of Anesthesiology, Weifang Medical University, Weifang, China.

PubMed

Insights

Autophagy, a cellular process, plays a dual role in cancer. This review explores how anesthetics impact tumor progression by modulating autophagy, offering insights for perioperative cancer treatment.

Area of Science:

  • Cellular Biology
  • Oncology
  • Anesthesiology

Background:

  • Autophagy is a fundamental cellular process crucial for maintaining homeostasis.
  • Autophagy exhibits a dual regulatory role in cancer development, influencing tumor progression.
  • Anesthetics can modulate tumor cell behavior and impact cancer progression.

Purpose of the Study:

  • To review the role of autophagy in cancer.
  • To examine the effects of different anesthetics on tumor progression.
  • To elucidate the molecular mechanisms of anesthetic-induced autophagy modulation in cancer.

Main Methods:

  • Literature review of autophagy, cancer, and anesthetics.
  • Analysis of studies on autophagy-targeted cancer therapies.
  • Exploration of molecular mechanisms linking anesthetics and autophagy in tumors.

Main Results:

  • Anesthetics can either promote or inhibit tumor progression by altering autophagy.
  • Different anesthetic agents have varying effects on cancer cells.
  • Specific molecular pathways mediate the interaction between anesthetics and autophagy.

Conclusions:

  • Anesthetics can be leveraged to suppress tumor development during the perioperative period.
  • Modulating autophagy presents a potential strategy for novel cancer therapies.
  • Further research into the anesthetic/autophagy system can guide clinical treatment and drug development.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
162
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K